Literature DB >> 21135538

Overexpression of Dyrk1A causes the defects in synaptic vesicle endocytosis.

Yoonju Kim1, Joohyun Park, Woo-Joo Song, Sunghoe Chang.   

Abstract

Trisomy 21-linked Dyrk1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A) overexpression is implicated in pathogenic mechanisms underlying mental retardation in Down syndrome (DS). It is known to phosphorylate multiple substrates including endocytic proteins in vitro, but the functional consequence of Dyrk1A-mediated phosphorylation on endocytosis has never been investigated. Here, we show that overexpression of Dyrk1A causes defects in clathrin-mediated endocytosis and specifically, in the recruitment of endocytic proteins to clathrin-coated pits in fibroblasts. Synaptic vesicle endocytosis also significantly slowed down as a result of Dyrk1A overexpression in cultured hippocampal neurons. These effects are dependent on Dyrk1A kinase activity. The inhibitory effect of Dyrk1A on synaptic vesicle endocytosis was confirmed in neuronal cultures derived from transgenic mice overexpressing Dyrk1A at levels found in DS. Pharmacological blockade of Dyrk1A with epigallocatechin gallate rescued the endocytic phenotypes found in transgenic neurons. Together, our results suggest that aberrant Dyrk1A-mediated phosphorylation of the endocytic machinery perturbs synaptic vesicle endocytosis, which may contribute to synaptic dysfunctions and cognitive deficits associated with DS.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21135538     DOI: 10.1159/000321994

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  15 in total

1.  A novel binding protein of single-minded 2: the mitotic arrest-deficient protein MAD2B.

Authors:  Xianfang Meng; Xiujuan Tian; Xiaolan Wang; Pan Gao; Chun Zhang
Journal:  Neurogenetics       Date:  2012-06-02       Impact factor: 2.660

2.  Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes.

Authors:  Jack-Christophe Cossec; Jérémie Lavaur; Diego E Berman; Isabelle Rivals; Alexander Hoischen; Samantha Stora; Clémentine Ripoll; Clotilde Mircher; Yann Grattau; Jean-Christophe Olivomarin; Fabrice de Chaumont; Magalie Lecourtois; Stylianos E Antonarakis; Joris A Veltman; Jean M Delabar; Charles Duyckaerts; Gilbert Di Paolo; Marie-Claude Potier
Journal:  Hum Mol Genet       Date:  2012-04-17       Impact factor: 6.150

3.  DYRK1A regulates the bidirectional axonal transport of APP in human-derived neurons.

Authors:  Iván Fernandez Bessone; Jordi Navarro; Emanuel Martinez; Karina Karmirian; Mariana Holubiec; Matias Alloatti; Livia Goto-Silva; Cayetana Arnaiz Yepez; Daniel Martins-de-Souza; Juliana Minardi Nascimento; Luciana Bruno; Trinidad M Saez; Stevens K Rehen; Tomás L Falzone
Journal:  J Neurosci       Date:  2022-07-08       Impact factor: 6.709

4.  Phosphorylation by Dyrk1A of clathrin coated vesicle-associated proteins: identification of the substrate proteins and the effects of phosphorylation.

Authors:  Noriko Murakami; David C Bolton; Elizabeth Kida; Wen Xie; Yu-Wen Hwang
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

5.  DYRK1A-mediated phosphorylation of GluN2A at Ser(1048) regulates the surface expression and channel activity of GluN1/GluN2A receptors.

Authors:  Cristina Grau; Krisztina Arató; José M Fernández-Fernández; Aitana Valderrama; Carlos Sindreu; Cristina Fillat; Isidre Ferrer; Susana de la Luna; Xavier Altafaj
Journal:  Front Cell Neurosci       Date:  2014-10-17       Impact factor: 5.505

Review 6.  DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome.

Authors:  Arnaud Duchon; Yann Herault
Journal:  Front Behav Neurosci       Date:  2016-06-03       Impact factor: 3.558

7.  Dual-specificity tyrosine-phosphorylation regulated kinase 1A Gene Transcription is regulated by Myocyte Enhancer Factor 2D.

Authors:  Pin Wang; Luanluan Wang; Long Chen; Xiulian Sun
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

8.  K63-linked ubiquitination of DYRK1A by TRAF2 alleviates Sprouty 2-mediated degradation of EGFR.

Authors:  Pengshan Zhang; Zhe Zhang; Yinkun Fu; Ying Zhang; Michael P Washburn; Laurence Florens; Min Wu; Chen Huang; Zhaoyuan Hou; Man Mohan
Journal:  Cell Death Dis       Date:  2021-06-11       Impact factor: 8.469

Review 9.  Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics.

Authors:  Nicole Créau
Journal:  Neural Plast       Date:  2012-07-12       Impact factor: 3.599

10.  Synaptic Vesicle Recycling Is Unaffected in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Jamie R K Marland; Karen J Smillie; Michael A Cousin
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.